Clinical Benefits of an Adherence Monitoring Program in the Management of Secondary Hyperparathyroidism with Cinacalcet: Results of a Prospective Randomized Controlled Study

Background/Aims. One of the causes of uncontrolled secondary hyperparathyroidism (sHPT) is patient's poor drug adherence. We evaluated the clinical benefits of an integrated care approach on the control of sHPT by cinacalcet. Methods. Prospective, randomized, controlled, multicenter, open-label...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Forni Ogna, Valentina, Pruijm, Menno, Zweiacker, Carole, Wuerzner, Grégoire, Tousset, Eric, Burnier, Michel
Formato: Artigo
Idioma:Inglês
Publicado: Hindawi Publishing Corporation 2013
Assuntos:
Clinical Study
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3732637/
https://ncbi.nlm.nih.gov/pubmed/23971019
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/104892
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares